Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long Term Study of 2 Isoniazid (INH) Prophylactic Regimens With Concomitant Cotrimoxazole (CTX) in HIV-infected Children - Impact on Morbidity, Mortality, Bacterial Resistance and Incidence of Tuberculosis

NCT00330304 is registered in ClinicalTrials.gov with University of Cape Town as lead sponsor.

NCT NCT00330304
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00330304 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long Term Study of 2 Isoniazid (INH) Prophylactic Regimens With Concomitant Cotrimoxazole (CTX) in HIV-infected Children - Impact on Morbidity, Mortality, Bacterial Resistance and Incidence of Tuberculosis
Lead sponsor
University of Cape Town
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2003
Completion date
November 15, 2011
Enrollment
450 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculosis